Carillon Tower Advisers Inc. increased its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,983 shares of the health services provider’s stock after purchasing an additional 1,175 shares during the period. Carillon Tower Advisers Inc. owned approximately 0.19% of LHC Group worth $6,075,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in LHCG. Bank of Montreal Can grew its stake in shares of LHC Group by 251.9% during the second quarter. Bank of Montreal Can now owns 2,481 shares of the health services provider’s stock worth $212,000 after purchasing an additional 1,776 shares during the period. Amalgamated Bank acquired a new stake in shares of LHC Group during the second quarter worth $429,000. Texas Permanent School Fund grew its stake in shares of LHC Group by 75.1% during the second quarter. Texas Permanent School Fund now owns 18,862 shares of the health services provider’s stock worth $1,614,000 after purchasing an additional 8,089 shares during the period. Alps Advisors Inc. acquired a new stake in shares of LHC Group during the second quarter worth $442,000. Finally, Piedmont Investment Advisors LLC grew its stake in shares of LHC Group by 96.2% during the second quarter. Piedmont Investment Advisors LLC now owns 6,838 shares of the health services provider’s stock worth $585,000 after purchasing an additional 3,352 shares during the period. 86.96% of the stock is owned by institutional investors and hedge funds.
A number of research firms have issued reports on LHCG. UBS Group began coverage on LHC Group in a research note on Thursday, November 15th. They issued a “buy” rating and a $109.00 target price for the company. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 7th. Robert W. Baird boosted their target price on LHC Group from $95.00 to $98.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. William Blair reissued a “buy” rating on shares of LHC Group in a research note on Thursday, November 1st. Finally, Craig Hallum cut LHC Group from a “buy” rating to a “hold” rating and decreased their target price for the company from $99.00 to $92.00 in a research note on Friday, October 26th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $105.92.
In other news, CEO Keith G. Myers sold 75,000 shares of the business’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the sale, the chief executive officer now directly owns 200,765 shares in the company, valued at $19,092,751.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 2,756 shares of the business’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $99.32, for a total value of $273,725.92. Following the completion of the sale, the chief operating officer now owns 104,512 shares in the company, valued at $10,380,131.84. The disclosure for this sale can be found here. Insiders own 6.80% of the company’s stock.
NASDAQ:LHCG opened at $104.87 on Monday. LHC Group, Inc. has a 1 year low of $58.65 and a 1 year high of $107.51. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $3.29 billion, a price-to-earnings ratio of 43.33, a price-to-earnings-growth ratio of 1.76 and a beta of 0.80.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, October 31st. The health services provider reported $0.95 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.95. The firm had revenue of $507.00 million during the quarter, compared to analysts’ expectations of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The company’s revenue was up 88.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 earnings per share. As a group, equities research analysts anticipate that LHC Group, Inc. will post 3.52 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2018/12/03/carillon-tower-advisers-inc-has-6-08-million-position-in-lhc-group-inc-lhcg.html.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Article: Fundamental Analysis and Individual Investors
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.